Skip to main content
. 2023 Feb 9;36(1):34–43. doi: 10.1089/jamp.2021.0061

FIG. 4.

FIG. 4.

Mean total DD (A) and FPF (B) of FF/UMEC/VI through the ELLIPTA DPI as measured using the eLung* for FF/UMEC/VI 100/62.5/25 μg and FF/UMEC/VI 200/62.5/25 μg. *Dose delivery performance of the ELLIPTA DPI was assessed using the eLung to replicate inhalation profiles previously recorded from patients with COPD or asthma (RES113817 and RES117178 studies) with three replicates for each flow rate. Error bars indicate 95% confidence and 95% coverage tolerance intervals around the mean. COPD, chronic obstructive pulmonary disease.